2-25234373-C-T

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 11P and 1B. PM5PP3PP5_Very_StrongBP4

The NM_022552.5(DNMT3A):​c.2645G>A​(p.Arg882His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000265 in 1,612,436 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAd4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R882S) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

DNMT3A
NM_022552.5 missense

Scores

12
5
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:17O:3

Conservation

PhyloP100: 7.90

Publications

505 publications found
Variant links:
Genes affected
DNMT3A (HGNC:2978): (DNA methyltransferase 3 alpha) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated. [provided by RefSeq, Mar 2016]
DNMT3A Gene-Disease associations (from GenCC):
  • Tatton-Brown-Rahman overgrowth syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Heyn-Sproul-Jackson syndrome
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-25234374-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 375884.
PP3
Multiple lines of computational evidence support a deleterious effect 11: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Dann, M_CAP, phyloP100way_vertebrate, PrimateAI, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
PP5
Variant 2-25234373-C-T is Pathogenic according to our data. Variant chr2-25234373-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 375881.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.38679647). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022552.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3A
NM_022552.5
MANE Select
c.2645G>Ap.Arg882His
missense
Exon 23 of 23NP_072046.2
DNMT3A
NM_175629.2
c.2645G>Ap.Arg882His
missense
Exon 23 of 23NP_783328.1
DNMT3A
NM_001320893.1
c.2189G>Ap.Arg730His
missense
Exon 18 of 18NP_001307822.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3A
ENST00000321117.10
TSL:1 MANE Select
c.2645G>Ap.Arg882His
missense
Exon 23 of 23ENSP00000324375.5
DNMT3A
ENST00000264709.7
TSL:1
c.2645G>Ap.Arg882His
missense
Exon 23 of 23ENSP00000264709.3
DNMT3A
ENST00000380746.8
TSL:1
c.2078G>Ap.Arg693His
missense
Exon 19 of 19ENSP00000370122.4

Frequencies

GnomAD3 genomes
AF:
0.000369
AC:
56
AN:
151936
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000508
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000442
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000219
AC:
55
AN:
251040
AF XY:
0.000214
show subpopulations
Gnomad AFR exome
AF:
0.000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.000544
Gnomad FIN exome
AF:
0.000277
Gnomad NFE exome
AF:
0.000158
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000254
AC:
371
AN:
1460500
Hom.:
0
Cov.:
31
AF XY:
0.000242
AC XY:
176
AN XY:
726560
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000389
AC:
13
AN:
33452
American (AMR)
AF:
0.000157
AC:
7
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.000575
AC:
15
AN:
26106
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39652
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86180
European-Finnish (FIN)
AF:
0.000244
AC:
13
AN:
53376
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.000257
AC:
286
AN:
1110930
Other (OTH)
AF:
0.000149
AC:
9
AN:
60352
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.301
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000369
AC:
56
AN:
151936
Hom.:
0
Cov.:
32
AF XY:
0.000323
AC XY:
24
AN XY:
74240
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000508
AC:
21
AN:
41362
American (AMR)
AF:
0.0000655
AC:
1
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.0000945
AC:
1
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000442
AC:
30
AN:
67940
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.283
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000803
Hom.:
0
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000593
AC:
72
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions as Germline
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar

Computational scores

Publications

Other links and lift over

dbSNP: rs147001633; hg19: chr2-25457242; COSMIC: COSV53036153; COSMIC: COSV53036153; API